Ruxolitinib Combination Therapies for Myeloproliferative Neoplasms

Dr Pemmaraju explains the rationale for ruxolitinib combination therapies in myeloproliferative neoplasm treatment.

EP: 1.Overview of the Types of Myeloproliferative Neoplasms

EP: 2.Current Standards of Care for Polycythemia Vera and Essential Thrombocytosis

EP: 3.Overview of Myelofibrosis and the Challenges of Diagnosis

EP: 4.Approved Systemic Treatment Options for Myelofibrosis

Now Viewing

EP: 5.Ruxolitinib Combination Therapies for Myeloproliferative Neoplasms

EP: 6.Single-Agent Investigational Therapies for Myeloproliferative Neoplasms

EP: 7.Major Unmet Needs in Myeloproliferative Neoplasm Management

Recent Videos